Last updated on September 2018

Dose Finding Study of MCI-186 in Acute Ischemic Stroke


Brief description of study

To investigate the efficacy and safety of MCI-186 (bolus followed by continuous infusion) in acute ischemic stroke patients through a double-blind, parallel-group comparison with the existing MCI-186 dosing regimen (administration twice daily for 14 days) as the control.

Clinical Study Identifier: NCT03346538

Contact Investigators or Research Sites near you

Start Over

Investigational site 04

Yamaguchi, Japan

Investigational site 26

Yamaguchi, Japan

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.